RESUMEN
In vivo 4-hydroxyamino[2-3H]quinoline 1-oxide-modified DNA and in vitro 4-acetoxyamino[2-3H]quinoline 1-oxide-modified DNA were enzymatically hydrolyzed, and the hydrolysates were analyzed by high-performance liquid chromatography. The two patterns were compared, and we showed that all of the high-performance liquid chromatography peaks which were recovered from in vivo-modified DNA were present in the hydrolysate of in vitro-modified DNA. Therefore, we used the in vitro 4-acetoxyamino[2-3H]quinoline 1-oxide-modified DNA to investigate the quinoline-purine adducts which are characteristics of the mode of action of the carcinogen 4-nitroquinoline 1-oxide. By comparison with the enzymatic hydrolysates of 4-acetoxyamino[2-3H]quinoline 1-oxide-modified covalent poly(deoxyadenylate-deoxythymidylate) X poly(deoxyadenylate-deoxythymidylate) and covalent poly(deoxyguanylate-deoxycytidylate) X poly(deoxyguanylate-deoxycytidylate) three nitroquinoline adducts were enumerated on the modified DNA. One of them was previously characterized as a C8-guanyl adduct. We proved that the two other are a guanine and an adenine adduct, respectively. A quinoline derivative was identified in the hydrolysates of the in vivo- and in vitro-modified DNAs as 4-aminoquinoline 1-oxide, the origin of which was postulated to be a degradation compound of one (or more) adduct(s). Moreover, the presence of two degradation compounds of the C8-guanyl adduct was shown in mild alkaline conditions. We suspected an imidazole ring-opened form.
Asunto(s)
4-Hidroxiaminoquinolina-1-Óxido/metabolismo , Aminoquinolinas/metabolismo , Carcinógenos/metabolismo , ADN/metabolismo , Polidesoxirribonucleótidos/metabolismo , Animales , Pollos , Cromatografía Líquida de Alta Presión , Poli dA-dT/metabolismo , Ratas , Ratas EndogámicasRESUMEN
Great quantities of chicken erythrocyte DNA with high levels of modification were obtained in vitro by reaction with 4-acetoxyaminoquinoline 1-oxide, a model ultimate carcinogen of 4-nitroquinoline 1-oxide. After enzymatic hydrolysis of the modified DNA, the three main adducts were separated and isolated by semipreparative high performance liquid chromatography. These three adducts were already characterized in vivo and in vitro in our previous work (S. Galiègue-Zouitina et al., Cancer Res., 45: 520-525, 1985). The structure of one of them was previously identified as N-(deoxyguanosin-8-yl)-4-aminoquinoline 1-oxide (B. Bailleul et al., Cancer Res., 41: 4559-4565, 1981). In this paper we have identified by mass spectroscopy and nuclear magnetic resonance the structures of the two other main adducts as 3-(deoxyguanosin-N2-yl)-4-aminoquinoline 1-oxide and 3-(deoxyadenosin-N6-yl)-4-aminoquinoline 1-oxide, respectively.
Asunto(s)
4-Nitroquinolina-1-Óxido , ADN , Nitroquinolinas , 4-Nitroquinolina-1-Óxido/toxicidad , Animales , Pollos , Cromatografía Líquida de Alta Presión , Eritrocitos/análisis , Espectroscopía de Resonancia Magnética , Espectrometría de Masas , Mutación , Nitroquinolinas/toxicidadRESUMEN
We have previously shown that the LAZ3/BCL6 gene encoding a potential transcription factor, is disrupted in B-diffuse large cell non-Hodgkin's lymphomas (NHL) with 3q27 chromosomal abnormalities involving the immunoglobulin (IG) genes. However, LAZ3 rearrangement also occurs in NHL bearing 3q27 translocations without involvement of the IG genes: for example the VAl cell line exhibits t(3;4)(q27;p11). In the present work we have used a RT-PCR method to detect and to sequence the LAZ3 mRNA products from the VAL cell line. We report that the consequence of the t(3;4) is the expression of a chimeric transcript of LAZ3 with a new gene encoding a small G-like protein, termed TTF (Translocation Three Four). Nucleotide sequence analysis of a 1.4 kb cDNA predicts that the TTF gene encodes a protein of 191 amino-acids similar to members of the RAS superfamily including HRAS (27% identical), RAB1A (30% identical) and RHO proteins: the human RAC1, RHOB and CDC42Hs proteins (respectively 43, 44 and 45% identical) and the yeast RHO2 protein (44% identical). Unlike most other small G proteins which are expressed ubiquitously, TTF was transcribed only in hemopoietic cells as a 2.2 kb transcript. TTF may define a new subgroup of RHO-like proteins.
Asunto(s)
Clonación Molecular , Proteínas de Unión al ADN/genética , Proteínas de Unión al GTP/genética , Factores de Transcripción/genética , Translocación Genética , Secuencia de Aminoácidos , Secuencia de Bases , Cromosomas Humanos Par 3 , Cromosomas Humanos Par 4 , ADN Complementario , Humanos , Datos de Secuencia Molecular , Filogenia , Proteínas Proto-Oncogénicas c-bcl-6 , ARN Mensajero/genética , Homología de Secuencia de Aminoácido , Homología de Secuencia de Ácido Nucleico , Células Tumorales CultivadasRESUMEN
We recently isolated the RhoH/TTF gene by its fusion to the LAZ3/BCL6 gene, in a non-Hodgkin's lymphoma (NHL) cell line, which bore a t(3;4)(q27;p11-13) translocation. This gene encodes a novel Rho GTP-binding protein and is specifically expressed in hematopoietic tissues. We made its precise mapping at band 4p13, and described its partial genomic structure. Using fluorescence in situ hybridization and molecular analyses, we report here on the rearrangement of the RhoH/TTF gene, at band 4p13, in four cases of NHL with t(3;4)(q27;p13) translocation and its fusion to the LAZ3/BCL6 gene at band 3q27, in three of these cases. RT-PCR analysis of two cases allowed the detection of variable fusion transcripts emerging from the rearranged alleles, and in one case, a deregulated expression of both RhoH/TTF and LAZ3/BCL6 genes, by promoter substitution, was observed. We also show here another rearrangement of the RhoH/TTF gene in a patient with multiple myeloma and t(4;14)(p13;q32) translocation, with breakage within the IGH gene. It is the first report which describes the recurrent chromosomal alteration of a GTP-binding protein encoding gene, in patients with hematopoietic malignancies.
Asunto(s)
Cromosomas Humanos Par 4 , Proteínas de Unión al GTP/genética , Reordenamiento Génico , Linfoma no Hodgkin/genética , Mieloma Múltiple/genética , Secuencia de Bases , Northern Blotting , Cromosomas Humanos Par 3 , Proteínas de Unión al ADN/genética , Femenino , Humanos , Cadenas Pesadas de Inmunoglobulina/genética , Hibridación Fluorescente in Situ , Persona de Mediana Edad , Datos de Secuencia Molecular , Proteínas Proto-Oncogénicas c-bcl-6 , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Translocación GenéticaRESUMEN
Duplex unwinding associated with DNA modification by 4-acetoxyaminoquinoline-1-oxide, a model ultimate carcinogen of 4-nitroquinoline-1-oxide, has been determined by the agarose gel electrophoresis band-shift method. An average unwinding angle per stable adduct of -15.1 degrees +/- 1.5 degrees for negatively supercoiled topoisomers and -6.5 degrees +/- 1.4 degrees for positively supercoiled topoisomers was obtained. Because of the different proportion of stable adducts (dGuo-N2-AQO, dGuo-C8-AQO, dAdo-N6-AQO) between negatively (8:1.5:0.5) and positively (5:2.5:1) supercoiled topoisomers, the difference in unwinding angles is suggestive of a diverse contribution of the various adducts to the overall conformational change. Since the largest unwinding angle was coupled with the highest proportion of dGuo-N2-AQO adduct, it is likely that this adduct is the most distortive lesion. A contribution of sites of base loss to DNA unwinding was also observed.
Asunto(s)
Aminoquinolinas/química , Daño del ADN , Ácido Apurínico/química , ADN Superhelicoidal/química , Electroforesis en Gel de Agar , Técnicas In Vitro , Conformación de Ácido Nucleico , PlásmidosRESUMEN
The ETS family proteins have a conserved DNA-binding domain and act as transcription factors. Three domains have been recently defined in human ETS-1 proteins and their role could depend upon the nature of alternative transcripts according to whether they possess or lack DNA binding and/or transcriptional activation domain and also point mutation that could affect these important domains. Expression of ETS-1 gene is very complex and is controlled at several levels: the initiation of transcription, alternative splicing, post-translational modification, and protein stability. As a selection apparently exists for ETS-1 gene activation in hematopoietic cells, we investigated a relation between quantitative and qualitative ETS-1 expression and leukemogenesis. Using Northern blot, polymerase chain reaction (PCR), and single strand conformation polymorphism (SSCP) methods, we analyzed quantitative and qualitative ETS-1 expression in a variety of hematological pathologies and cell lines of different origin. Two ETS-1 transcripts of 6.8 and 2.7 kb, resulting from differential polyadenylation site utilization and exhibiting different stability, were observed. We identified, in a great number of patients, the four alternative ETS-1 products, but the relative extent significance of the four transcripts was very different from one patient to another. A non-conservative mutation observed in one case of T-cell acute lymphoblastic leukemia (T-ALL) and in the ETS-1 transactivation domain raised the question of suppressor activity for some ETS-1 products, as it is now known that activators and repressors can be encoded by the same gene and consistently co-expressed in vivo.
Asunto(s)
Leucemia/genética , Proteínas Proto-Oncogénicas/genética , Proto-Oncogenes , ARN Mensajero/análisis , Secuencia de Bases , Northern Blotting , Expresión Génica , Humanos , Leucemia/metabolismo , Datos de Secuencia Molecular , Mutación , Reacción en Cadena de la Polimerasa , Proteína Proto-Oncogénica c-ets-1 , Proteínas Proto-Oncogénicas c-ets , Proto-Oncogenes/genética , Factores de Transcripción/genética , Transcripción Genética , Activación TranscripcionalRESUMEN
Chromosome 11q23 is frequently a site of chromosomal translocation in both acute leukemias and chronic lymphoproliferative disorders. In the former, an 8 kb region within the MLL gene is consistently involved, whereas in the latter breakpoints appear to be heterogeneous. In a B cell acute leukemia cell line with t(14;18)(q32.3;q21.3) we have previously demonstrated a reciprocal translocation between the LAZ3/BCL6 gene at 3q27 and the B cell specific transcriptional coactivator gene BOB-1 at 11q23.1, implicating BOB-1 as a potential proto-oncogene. To confirm the chromosomal localization of BOB-1 we have mapped it by FISH to 11q23.1. It lay immediately telomeric of the ATM gene. We have also investigated the frequency of BOB-1 rearrangements in a panel of 32 cell lines and 71 patient samples. In one case of T cell prolymphocytic leukemia-a disease where 11q23 abnormalities are observed-a chromosomal rearrangement was identified 3.3-0.9 kb centromeric of the 3' end of the gene. Thus, there is a heterogeneity of breakpoints associated with BOB-1 while the frequency of the gene's involvement in lymphoproliferative diseases is low.
Asunto(s)
Trastornos Linfoproliferativos/genética , Transactivadores/genética , Secuencia de Bases , Cromosomas Humanos Par 11 , Sondas de ADN , ADN de Neoplasias/genética , Exones , Reordenamiento Génico , Humanos , Hibridación Fluorescente in Situ , Cariotipificación , Leucemia Prolinfocítica/genética , Leucemia-Linfoma de Células T del Adulto/genética , Datos de Secuencia Molecular , Proto-Oncogenes Mas , Células Tumorales CultivadasRESUMEN
The LAZ3/BCL6 gene on chromosone 3q27 is recurrently disrupted in B cell non-Hodgkin's lymphomas by translocations involving immunoglobulin genes or other chromosone regions. We have cloned the breakpoint region and chromosone derivatives of the t(3;11)(q27;q23.1) translocation, present in a B cell leukemia cell line (Karpas 231), which define a novel 11q23.1 breakpoint site. As a consequence of the translocation, LAZ3 regulatory regions upstream of non-coding exon 2 are replaced by those of BOB1/OBF1, a recently described B cell-specific coactivator of octamer-binding transcription factors. A detailed structural study of the BOB1/OBF1 genomic DNA and of a nearly full-length cDNA revealed particular features in the 3' untranslated region, such as an Alu motif and a polymorphic tetranucleotide microsatellite. Two mutations leading to two potential amino acid changes in the C-terminal region, were also detected in one allele of a lymphoma B cell line, Raji. Due to its cell-specific expression and role as a coactivating transcription factor, chromosomal translocation and/or point mutation of BOB1/OBF1 may contribute to B cell tumorigenesis.
Asunto(s)
Cromosomas Humanos Par 11 , Cromosomas Humanos Par 3 , Clonación Molecular , Proteínas de Unión al ADN/biosíntesis , Leucemia de Células B/genética , Proteínas Proto-Oncogénicas/biosíntesis , Transactivadores/biosíntesis , Factores de Transcripción/biosíntesis , Translocación Genética , Secuencia de Aminoácidos , Secuencia de Bases , Línea Celular , Mapeo Cromosómico , Cartilla de ADN , ADN Complementario , Proteínas de Unión al ADN/genética , Exones , Expresión Génica , Genes de Inmunoglobulinas , Humanos , Intrones , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Proteínas Proto-Oncogénicas/genética , Proteínas Proto-Oncogénicas c-bcl-6 , Secuencias Reguladoras de Ácidos Nucleicos , Mapeo Restrictivo , Transactivadores/genética , Factores de Transcripción/genética , Células Tumorales Cultivadas , Dedos de ZincRESUMEN
Both the initial velocity and the overall methylation of Ac-4HAQO modified DNA by a calf brain DNA (cytosine-5-)-methyltransferase are increased as compared to native DNA. The affinity of the modified DNA for the enzyme decreases as a function of the extent of the modification. Heat-denatured, single-stranded DNA shows exactly the opposite results: the more it is modified, the less it is methylated. The poly(dG-dC) X poly(dG-dC) modified by 4NQO is as well methylated as the non-modified one. The carcinogen may induce a tertiary structure favouring the 'walking' of the enzyme along the DNA. The hypermethylation caused by this carcinogen could have a significance in gene activity and cellular differentiation.
Asunto(s)
Aminoquinolinas/metabolismo , Encéfalo/enzimología , Carcinógenos/metabolismo , ADN (Citosina-5-)-Metiltransferasas/metabolismo , ADN/metabolismo , Metiltransferasas/metabolismo , Polidesoxirribonucleótidos/metabolismo , Animales , Bovinos , Pollos , ADN/sangre , Cinética , Metilación , Especificidad por SustratoRESUMEN
INTRODUCTION: Chromosomal translocations involving the chromosome 3q27 region are common in B-cell non-Hodgkin's lymphoma (NHL), mainly diffuse large cell lymphoma (DLCL) and less often in follicular lymphoma. Most of these rearrangements involve the same major translocation cluster (MTC) on the 3q27 region, disrupting the LAZ3/BCL6 gene. Some of those translocations are difficult to detect by cytogenetic analysis and/or Southern-blot analysis. In the present report we used a FISH assay to improve the detection of LAZ3/BCL6 rearrangements. METHODS: We isolated a YAC clone (803g3), containing the BCL6 gene, in order to analyze by FISH 19 cases of B-cell non-Hodgkin's lymphoma with cytogenetically detectable 3q27 rearrangement, including reciprocal translocation in 11 cases, deletion in two cases, and addition of undefined chromosomal material on 3q27 in six cases. RESULTS: In the 11 cases with reciprocal translocation, FISH results confirmed cytogenetic data and showed disruption of the LAZ3 region: four t(3;4)(q27;p13), two t(3;11)(q27;q23.1), four t(3;14)(q27;q32) and one t(2;3)(p12;q27). In two of the cases, reciprocal t(3;14) was associated with other cytogenetically detectable abnormalities of 3q27, but FISH showed that they did not affect the LAZ3 gene region. FISH demonstrated a reciprocal translocation with LAZ3 gene rearrangement in two of the six patients with add 3q27: one t(3;11) and one t(3;14). In the two patients with del(3q27), one had two 3q27 FISH signals and one had only one 3q27 FISH signal, but no LAZ3 gene rearrangement was observed. CONCLUSION: We have identified a YAC containing the LAZ3/BCL6 gene. This YAC probe could be useful in clinical practice to demonstrate LAZ3 rearrangements by FISH analysis on tumor samples in NHL.
Asunto(s)
Proteínas de Unión al ADN/genética , Reordenamiento Génico , Linfoma de Células B/genética , Linfoma no Hodgkin/genética , Translocación Genética , Southern Blotting , Centrómero/genética , Mapeo Cromosómico , Cromosomas Artificiales de Levadura , Femenino , Humanos , Hibridación Fluorescente in Situ , Cariotipificación , Linfoma de Células B/patología , Masculino , Reacción en Cadena de la Polimerasa , Proteínas Proto-Oncogénicas c-bcl-6 , Factores de Transcripción/genética , Células Tumorales CultivadasRESUMEN
We report four cases of follicular lymphoma with both t(14;18)(q32;q21) and the newly characterized t(3;4)(q27;p13). Molecular investigation confirmed LAZ3 (BCL6) rearrangement for all patients. The 3q27 aberrations have been rarely described in low-grade lymphomas and may represent secondary events whose implication remains to be elucidated.
Asunto(s)
Cromosomas Humanos , Proteínas de Unión al ADN/genética , Linfoma Folicular/genética , Proteínas Proto-Oncogénicas/genética , Factores de Transcripción/genética , Translocación Genética , Adulto , Anciano , Southern Blotting , Cromosomas Humanos Par 14 , Cromosomas Humanos Par 18 , Cromosomas Humanos Par 3 , Cromosomas Humanos Par 4 , Femenino , Reordenamiento Génico de Linfocito B , Humanos , Cariotipificación , Linfoma Folicular/tratamiento farmacológico , Linfoma no Hodgkin , Persona de Mediana Edad , Proteínas Proto-Oncogénicas c-bcl-6 , Dedos de Zinc/genéticaRESUMEN
Three cases of (3;13)(q27;q14) translocation observed in different histological types of non-Hodgkin lymphomas (NHLs) are reported here. This new recurring translocation in NHL was secondary in at least two of the patients because it was associated with another specific change [i.e., t(8;14) (q24;q32) in Burkitt lymphoma and t(14;18)(q32;q21) in typical follicular lymphoma]. In two of the cases for which molecular analysis was performed, a rearrangement of the LAZ-3/BCK-6 gene was found.
Asunto(s)
Aberraciones Cromosómicas/genética , Cromosomas Humanos Par 13/genética , Cromosomas Humanos Par 3/genética , Linfoma no Hodgkin/genética , Translocación Genética/genética , Adulto , Anciano , Linfoma de Burkitt/genética , Trastornos de los Cromosomas , Femenino , Reordenamiento Génico/genética , Humanos , Cariotipificación , Linfoma Folicular/genética , Linfoma de Células B Grandes Difuso/genéticaRESUMEN
2-3H-Labelled 4-acetoxyaminoquinoline-1-oxide (Ac-4 HAQO), the ultimate carcinogen model of 4-nitroquinoline-1-oxide, was reacted in vitro with native and denatured DNA. We found that Ac-4 HAQO is 2- to 3-fold more reactive than diAc-4 HAQO, another ultimate carcinogen model of 4 NQO which was previously studied [Galiègue et al. (1980) Biochim. Biophys. Acta, 609, 383-391]. Ac-4 HAQO-modified DNA is thermally destabilized: when 1% of the bases of DNA were modified by Ac-4 HAQO, its melting temperature decreased 1.2 degrees C. Enzymatic degradation of Ac-4 HAQO-modified native and denatured DNA's to nucleosides was performed. The hydrolysates were analyzed, first with a simple chromatographic system, and then by h.p.l.c. The compounds recovered from the modified polymers were characterized by h.p.l.c. and a variation in their respective amounts as a function of the secondary structure of DNA was observed. Especially, the N-(deoxyguanosin-(C8-yl)-4-aminoquinoline-1-oxide, the so called dG III adduct, was recovered from DNA, and its amount was evaluated to be approximately 3.5-fold greater in the case of denatured DNA than in the case of native DNA.
Asunto(s)
4-Nitroquinolina-1-Óxido , Aminoquinolinas , Carcinógenos , ADN/metabolismo , Endodesoxirribonucleasas/metabolismo , Nitroquinolinas , Fosfatasa Alcalina/metabolismo , Animales , Bovinos , Pollos , Desoxirribonucleasa I , Eritrocitos , Escherichia coli/enzimología , Intestinos/enzimología , Neurospora crassa/enzimología , Páncreas/enzimología , Hidrolasas Diéster Fosfóricas/metabolismo , Venenos de Serpiente , Bazo/enzimologíaRESUMEN
Poly(dG-dC).poly(dG-dC) has been modified by reaction with 4-acetoxyaminoquinoline 1-oxide (Ac-4 HAQO), the ultimate carcinogen of 4-nitroquinoline 1-oxide. The circular dichroism (CD) spectra of the modified and unmodified polymers have been compared under various experimental conditions. The CD spectra were recorded in 1 mM phosphate, 50% (v/v) ethanol, 3.8 M LiCl and 95% (v/v) ethanol, conditions in which poly(dG-dC).poly(dG-dC) adopts the B-, Z-, C- and A-form respectively. In 1 mM phosphate buffer, poly(dG-dC).poly(dG-dC) modified by Ac-4 HAQO seems not to contain regions in the Z-form. Z-form induction could be progressively obtained by the addition of ethanol as follows: in the buffer with about 30% ethanol the modified polymer started to adopt the Z structure, while 40% of ethanol in the buffer was necessary for the unmodified polymer. In the 50% ethanol-1 mM phosphate buffer mixture (v/v), poly(dG-dC).poly(dG-dC) was entirely in the Z-form while poly(dG-dC).poly(dG-dC) modified by Ac-4 HAQO remained partially in the B-form. Enzymatic digestions with the nuclease S1 which is specific of the single-stranded DNA were carried out in order to support the modified poly(dG-dC).poly(dG-dC) CD study conclusions. The role played by the two major adducts on the conformational characteristics of modified polymer is discussed.
Asunto(s)
Aminoquinolinas , Carcinógenos , Polidesoxirribonucleótidos , Cromatografía Líquida de Alta Presión , Dicroismo Circular , Endonucleasas/metabolismo , Cinética , Conformación de Ácido Nucleico , Endonucleasas Específicas del ADN y ARN con un Solo Filamento , TermodinámicaRESUMEN
Native and denatured DNAs and polynucleotides were modified by 4-acetoxyaminoquinoline-1-oxide, the ultimate carcinogen of 4-nitroquinoline-1-oxide (4 NQO). The N-( deoxyguanosin -C8-yl)-4-aminoquinoline-1-oxide adduct, the so-called "dG III," was quantified on the DNA and on poly(dG-dC) in absorption spectroscopy, by using a spectral property of dG III, i.e., the variation of the absorption spectrum as a function of the pH. Using the "free-dG III" absorption reference spectra, a simple graphic determination of the percentage of dG III was established by recording the absorption spectra of the 4-acetoxyaminoquinoline-1-oxide-modified polymers. It was found that the dG III adduct accounts for about 30% of the total modification in the case of native modified DNA and poly(dG-dC) and for about 70% in the case of denatured modified DNA.
Asunto(s)
4-Nitroquinolina-1-Óxido/metabolismo , Aminoquinolinas/análisis , Aminoquinolinas/metabolismo , Carcinógenos/metabolismo , ADN/análisis , Desoxiguanosina/análogos & derivados , Nitroquinolinas/metabolismo , Desoxiguanosina/análisis , Concentración de Iones de Hidrógeno , Polidesoxirribonucleótidos/análisis , Espectrofotometría , Espectrofotometría UltravioletaRESUMEN
Alkaline pH treatment of N-(deoxyguanosin-8-yl)-4-amino-quinoline 1-oxide forms two quinoline derivatives. The two compounds were analyzed together by mass and 500 MHz 1H-n.m.r. spectroscopies and were identified as two 7,8-guanine ring-opened rotamers: 1-(1'-deoxyriboside)-1-[6-(2,5-diamino-4-oxo-pyrimidinyl)]-3-(4-quino linyl 1-oxide) urea.
Asunto(s)
Aminoquinolinas , Desoxiguanosina/análogos & derivados , Hidrólisis , Espectroscopía de Resonancia Magnética , Espectrometría de MasasRESUMEN
A comparison of the mutagenic potency of the N2 and the C8 guanylarylation of DNA by 4-nitroquinoline 1-oxide (4NQO) was established. The induced mutagenicity by the N2 guanine adduct is dependent on the SOS functions in the host and requires the umuC gene product. This lesion is repaired by the excision repair system and efficiently blocks the replication machinery. The data obtained with the C8 adduct show that this lesion is weakly toxic in the wild-type strain Escherichia coli probably because the efficiency of the replication is affected. This adduct is three times less mutagenic than the N2 adduct. These results suggest that in vivo the high mutagenicity of 4NQO can mainly be ascribed to the N2 guanine adduct.
Asunto(s)
4-Nitroquinolina-1-Óxido/farmacología , Reparación del ADN , ADN/efectos de los fármacos , Guanina , Mutágenos , Mutación , Nitroquinolinas/farmacología , Respuesta SOS en Genética , ADN Polimerasa Dirigida por ADN/metabolismo , Escherichia coli/efectos de los fármacos , Escherichia coli/genética , Cinética , Pruebas de Mutagenicidad , Plásmidos/efectos de los fármacos , Fagos T/enzimologíaRESUMEN
When the chemical carcinogen 4-nitroquinoline 1-oxide binds to DNA in vitro, two major adducts are formed, both at guanine residues, but at different positions, i.e. the C8 or the N2 position. Well-defined adducts (either C8 or N2 guanine adducts) can be formed in vitro by reacting DNA with 4-actoxyaminoquinoline 1-oxide (Ac-4HAQO) under different reaction conditions. Forward mutations induced by each of both main 4NQO adducts in the tetracycline resistance gene of pBR322 were determined. In total, 30 independent 4NQO-induced mutations were characterized, showing mainly base-pair substitution mutations and some frameshift mutations. We have observed that the 5' neighbouring base influences the specificity of dGuo-N2-AQO induced base-pair substitutions mutagenesis; a similar effect does not occur with dGuo-C8-AQO. This study reveals the importance of the N2 guanine adduct in the mutagenesis induced by 4NQO in vivo.
Asunto(s)
4-Nitroquinolina-1-Óxido/metabolismo , Aminoquinolinas/toxicidad , ADN/metabolismo , Desoxiguanosina/análogos & derivados , Escherichia coli/efectos de los fármacos , Secuencia de Aminoácidos , Aminoquinolinas/metabolismo , Desoxiguanosina/metabolismo , Desoxiguanosina/toxicidad , Escherichia coli/genética , Datos de Secuencia Molecular , Pruebas de MutagenicidadRESUMEN
The human nuclear co-repressor 2 (N-CoR2) gene (NCOR2, previously called silencing mediator for retinoid and thyroid hormone receptor SMRT) is recruited to nuclear and non-nuclear receptors in a large repressing complex containing also N-CoR1, mSin3 and HDACs. This large complex represses transcription in absence of ligand. Herein we report the high- resolution and refined mapping of NCOR2 at the boundary of sub-bands 12q24.23 and 12q24.31, and its intron/exon structure. The gene contains 45 exons. This information should allow further study of potential NCOR2 genomic alteration in some subsets of malignancies.
Asunto(s)
Cromosomas Humanos Par 12/genética , Proteínas de Unión al ADN/genética , Exones/genética , Hibridación Fluorescente in Situ , Intrones/genética , Proteínas Represoras/genética , Bandeo Cromosómico , Clonación Molecular , Humanos , Co-Represor 2 de Receptor Nuclear , Mapeo Físico de CromosomaRESUMEN
The RhoH/TTF (ARHH) gene encodes a new member of the Ras superfamily of small GTPases. The gene was identified by fusion to the BCL6/LAZ3 oncogene in an initially described t(3;4)(q27;p11) translocation in a non-Hodgkin's lymphoma cell line. The predicted amino acid sequence of the RhoH/TTF gene product includes Rho-like GTPase structural motifs. The RhoH/TTF gene is restrictively expressed in hematopoietic cells and tissues. Mutations in the human RAS genes have been shown previously to be tumorigenic; in the search for a potential implication of the RhoH/TTF gene in hemopoietic malignancies, we established its genomic structure. The RhoH/TTF gene spans 35 kb and contains two exons, with the second bearing the entire amino-acid-coding region. Chromosomal mapping, by FISH experiments, places the RhoH/TTF gene on the short arm of chromosome 4, band p13.